FDG-PET/CT in der onkologie

B. J. Krause; T. Beyer; A. Bockisch; D. Delbeke; J. Kotzerke; V. Minkov; M. Reiser; N. Willich; P. Bartenstein; R. P. Baum; W. Burchert; U. Haberkorn; R. Kluge; W. H. Knapp; T. Kuwert; E. Nitzsche; S. N. Reske; P. Reuland; H. Schicha; O. Schober; M. Schwaiger; U. Stabell; J. Van Den Hoff

doi:10.3413/nukmed-282

FDG-PET/CT in der onkologie

Translated title of the contribution: FDG-PET/CT in oncology

B. J. Krause
, T. Beyer
, A. Bockisch
, D. Delbeke
, J. Kotzerke
, V. Minkov
, M. Reiser
, N. Willich
, P. Bartenstein
, R. P. Baum
, W. Burchert
, U. Haberkorn
, R. Kluge
, W. H. Knapp
, T. Kuwert
, E. Nitzsche
, S. N. Reske
, P. Reuland
, H. Schicha
, O. Schober

M. Schwaiger, U. Stabell, J. Van Den Hoff

TUM Emeriti of Excellence

Research output: Contribution to journal › Review article › peer-review

59 Scopus citations

Abstract

FDG-PET/CT examinations combine metabolic and morphologic imaging within an integrated procedure. Over the past decade PET/CT imaging has gained wide clinical acceptance in the field of oncology. This FDG-PET/CT guideline focuses on indications, data acquisition and processing as well as documentation of FDG-PET/CT examinations in oncologic patients within a clinical and social context specific to Germany. Background information and definitions are followed by examples of clinical and research applications of FDG-PET/CT. Furthermore, protocols for CT scanning (low dose and contrast-enhanced CT) and PET emission imaging are discussed. Documentation and reporting of examinations are specified. Image interpretation criteria and sources of errors are discussed. Quality control for FDG and PET/CT-systems, qualification requirements of personnel as well as legal aspects are presented.

Translated title of the contribution	FDG-PET/CT in oncology
Original language	German
Pages (from-to)	291-301
Number of pages	11
Journal	NuklearMedizin
Volume	46
Issue number	6
DOIs	https://doi.org/10.3413/nukmed-282
State	Published - 2007

Access to Document

10.3413/nukmed-282

Cite this

Krause, B. J., Beyer, T., Bockisch, A., Delbeke, D., Kotzerke, J., Minkov, V., Reiser, M., Willich, N., Bartenstein, P., Baum, R. P., Burchert, W., Haberkorn, U., Kluge, R., Knapp, W. H., Kuwert, T., Nitzsche, E., Reske, S. N., Reuland, P., Schicha, H., ... Van Den Hoff, J. (2007). FDG-PET/CT in der onkologie. NuklearMedizin, 46(6), 291-301. https://doi.org/10.3413/nukmed-282

@article{59c2096a1b654ef3ab31cc3aea330d08,

title = "FDG-PET/CT in der onkologie",

abstract = "FDG-PET/CT examinations combine metabolic and morphologic imaging within an integrated procedure. Over the past decade PET/CT imaging has gained wide clinical acceptance in the field of oncology. This FDG-PET/CT guideline focuses on indications, data acquisition and processing as well as documentation of FDG-PET/CT examinations in oncologic patients within a clinical and social context specific to Germany. Background information and definitions are followed by examples of clinical and research applications of FDG-PET/CT. Furthermore, protocols for CT scanning (low dose and contrast-enhanced CT) and PET emission imaging are discussed. Documentation and reporting of examinations are specified. Image interpretation criteria and sources of errors are discussed. Quality control for FDG and PET/CT-systems, qualification requirements of personnel as well as legal aspects are presented.",

keywords = "FDG, Guideline, Oncology, PET/CT",

author = "Krause, \{B. J.\} and T. Beyer and A. Bockisch and D. Delbeke and J. Kotzerke and V. Minkov and M. Reiser and N. Willich and P. Bartenstein and Baum, \{R. P.\} and W. Burchert and U. Haberkorn and R. Kluge and Knapp, \{W. H.\} and T. Kuwert and E. Nitzsche and Reske, \{S. N.\} and P. Reuland and H. Schicha and O. Schober and M. Schwaiger and U. Stabell and \{Van Den Hoff\}, J.",

year = "2007",

doi = "10.3413/nukmed-282",

language = "Deutsch",

volume = "46",

pages = "291--301",

journal = "NuklearMedizin",

issn = "0029-5566",

publisher = "Georg Thieme Verlag",

number = "6",

}

Krause, BJ, Beyer, T, Bockisch, A, Delbeke, D, Kotzerke, J, Minkov, V, Reiser, M, Willich, N, Bartenstein, P, Baum, RP, Burchert, W, Haberkorn, U, Kluge, R, Knapp, WH, Kuwert, T, Nitzsche, E, Reske, SN, Reuland, P, Schicha, H, Schober, O, Schwaiger, M, Stabell, U & Van Den Hoff, J 2007, 'FDG-PET/CT in der onkologie', NuklearMedizin, vol. 46, no. 6, pp. 291-301. https://doi.org/10.3413/nukmed-282

TY - JOUR

T1 - FDG-PET/CT in der onkologie

AU - Krause, B. J.

AU - Beyer, T.

AU - Bockisch, A.

AU - Delbeke, D.

AU - Kotzerke, J.

AU - Minkov, V.

AU - Reiser, M.

AU - Willich, N.

AU - Bartenstein, P.

AU - Baum, R. P.

AU - Burchert, W.

AU - Haberkorn, U.

AU - Kluge, R.

AU - Knapp, W. H.

AU - Kuwert, T.

AU - Nitzsche, E.

AU - Reske, S. N.

AU - Reuland, P.

AU - Schicha, H.

AU - Schober, O.

AU - Schwaiger, M.

AU - Stabell, U.

AU - Van Den Hoff, J.

PY - 2007

Y1 - 2007

N2 - FDG-PET/CT examinations combine metabolic and morphologic imaging within an integrated procedure. Over the past decade PET/CT imaging has gained wide clinical acceptance in the field of oncology. This FDG-PET/CT guideline focuses on indications, data acquisition and processing as well as documentation of FDG-PET/CT examinations in oncologic patients within a clinical and social context specific to Germany. Background information and definitions are followed by examples of clinical and research applications of FDG-PET/CT. Furthermore, protocols for CT scanning (low dose and contrast-enhanced CT) and PET emission imaging are discussed. Documentation and reporting of examinations are specified. Image interpretation criteria and sources of errors are discussed. Quality control for FDG and PET/CT-systems, qualification requirements of personnel as well as legal aspects are presented.

AB - FDG-PET/CT examinations combine metabolic and morphologic imaging within an integrated procedure. Over the past decade PET/CT imaging has gained wide clinical acceptance in the field of oncology. This FDG-PET/CT guideline focuses on indications, data acquisition and processing as well as documentation of FDG-PET/CT examinations in oncologic patients within a clinical and social context specific to Germany. Background information and definitions are followed by examples of clinical and research applications of FDG-PET/CT. Furthermore, protocols for CT scanning (low dose and contrast-enhanced CT) and PET emission imaging are discussed. Documentation and reporting of examinations are specified. Image interpretation criteria and sources of errors are discussed. Quality control for FDG and PET/CT-systems, qualification requirements of personnel as well as legal aspects are presented.

KW - FDG

KW - Guideline

KW - Oncology

KW - PET/CT

UR - https://www.scopus.com/pages/publications/37349114413

U2 - 10.3413/nukmed-282

DO - 10.3413/nukmed-282

M3 - Übersichtsartikel

C2 - 18084685

AN - SCOPUS:37349114413

SN - 0029-5566

VL - 46

SP - 291

EP - 301

JO - NuklearMedizin

JF - NuklearMedizin

IS - 6

ER -

FDG-PET/CT in der onkologie

Abstract

Access to Document

Other files and links

Fingerprint

Cite this